Page last updated: 2024-09-04

hyoscyamine and dicumarol

hyoscyamine has been researched along with dicumarol in 2 studies

Compound Research Comparison

Studies
(hyoscyamine)
Trials
(hyoscyamine)
Recent Studies (post-2010)
(hyoscyamine)
Studies
(dicumarol)
Trials
(dicumarol)
Recent Studies (post-2010) (dicumarol)
991552,26033110

Protein Interaction Comparison

ProteinTaxonomyhyoscyamine (IC50)dicumarol (IC50)
CholinesteraseHomo sapiens (human)0.0026
Cytochrome P450 2C9 Homo sapiens (human)0.3
NADHomo sapiens (human)0.2585
Mitogen-activated protein kinase 1Homo sapiens (human)4.426
Proprotein convertase subtilisin/kexin type 7Homo sapiens (human)1.3

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

2 other study(ies) available for hyoscyamine and dicumarol

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012